Literature DB >> 17459845

Necrotizing encephalitis of unknown cause in Fennoscandian Arctic foxes (Alopex lagopus).

Anna-Lena Berg1, Dolores Gavier-Widén, Kristina Nilsson, Frederik Widén, Mikael Berg, Sune Gregorius, Erik Agren, Maria Erlandsson, Torsten Mörner.   

Abstract

A neurologic disease affected a colony of endangered Fennoscandian arctic foxes (Alopex lagopus) kept in captivity for breeding purposes. Several outbreaks of disease occurred between 1994 and 2004. The clinical signs included ataxia, indications of anosmia, blindness, and abnormal behavior. The disease was characterized by severe necrotizing encephalitis affecting mostly the cranial cerebrum, basal ganglia, and olfactory bulbs. Investigations to identify the etiology of the disease included testing for several infectious agents known to cause encephalitis in carnivores. Tests for Toxoplasma gondii, Encephalitozoon cuniculi, Neospora caninum, canine distemper virus, rabies, adenovirus type 1, Borna disease virus, and Listeria monocytogenes were negative. The colony was closed, and the cause of the disease remains undetermined.

Entities:  

Mesh:

Year:  2007        PMID: 17459845     DOI: 10.1177/104063870701900121

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  3 in total

1.  Chronic Infections in Mammals Due to Microsporidia.

Authors:  Bohumil Sak; Martin Kváč
Journal:  Exp Suppl       Date:  2022

2.  Pearsonema (syn Capillaria) plica associated cystitis in a Fennoscandian arctic fox (Vulpes lagopus: a case report.

Authors:  Xavier Fernández-Aguilar; Roland Mattsson; Tomas Meijer; Eva Osterman-Lind; Dolores Gavier-Widén
Journal:  Acta Vet Scand       Date:  2010-06-12       Impact factor: 1.695

3.  Screening red foxes (Vulpes vulpes) for possible viral causes of encephalitis.

Authors:  Manon Bourg; Daniel Nobach; Sibylle Herzog; Hildburg Lange-Herbst; Anne Nesseler; Hans-Peter Hamann; Sabrina Becker; Dirk Höper; Bernd Hoffmann; Markus Eickmann; Christiane Herden
Journal:  Virol J       Date:  2016-09-02       Impact factor: 4.099

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.